Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1998
11/10/1998US5834214 Quantitative analysis of blood sample using immunoassay
11/10/1998US5834213 Screening system and assay for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription
11/10/1998US5834210 Stable troponin subunits and complexes
11/10/1998US5834209 Bcl-x/bcl-2 associated cell death regulator
11/10/1998US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5834187 Sequence and analysis of LKP pilin structural genes and the LKP pili operon of nontypable Haemophilus influenzae
11/10/1998US5834186 Regulatable RNA molecule
11/10/1998US5834183 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
11/10/1998US5834179 Morphogenic protein compositions of matter
11/10/1998US5834029 Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
11/10/1998US5834028 Storage stable solutions with maltose, lactose or sucrose and arginine hydrochloride; for treatment or prevention of blood coagulation disorders
11/10/1998US5833995 Innoculating with a polypeptide comprising an anigenic portion of the virus stuctural protein
11/10/1998US5833993 Feline immunodeficiency virus vaccine
11/10/1998US5833991 A glycine-rich amino acid sequence is inserted into a fusion protein to prevent an immunogenic response; gene therapy; transfer vectors; vaccines
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998US5833989 Complement receptor type 1 protein was encoded by plasmides having no more three inserted short consensus repeats nucleotide; use in inflammatory, brain, nevous system and immune disorders
11/10/1998US5833988 Noninvasive drug delivery across the blood-brain barrier by administering a conjugate of an antibody, and either a nerve growth factor or neurotrophic factor; treating alzheimer's disease, stroke, epilepsy, parkinson's disease
11/10/1998US5833986 Methods of inhibiting the growth of neoplasia using a monoclonal antibody against α platelet derived growth factor receptor
11/10/1998US5833985 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
11/10/1998US5833983 Interleukin 2 receptor and applications thereof
11/10/1998US5833982 Anticoagulants
11/10/1998US5833980 Inoculating poultry, live virus vaccine
11/10/1998US5833979 Methods and compositions of growth control for cells encapsulated within bioartificial organs
11/10/1998US5833976 Administering to reduce levels of tumor necrosis factor; modulation of interleukins 1 and 6; post-operative septic shock treatment
11/10/1998US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
11/10/1998US5833943 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
11/10/1998US5833942 Cyclic peptide derivatives of somatostatin; radiodiagnosis, therapy
11/10/1998CA2050786C An antimicrobial peptide and an antimicrobial composition
11/10/1998CA1340122C Modifications of somatotropins for enhanced stability
11/09/1998WO1998039438A1 Antisense compounds to cd14
11/09/1998CA2253877A1 Antisense compounds to cd14
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/06/1998CA2204572A1 Transgenic mice expressing hiv-1 in immune cells and uses thereof as an animal model of aids
11/05/1998WO1998049560A1 Cadherin-11 as an indicator of viable pregnancy
11/05/1998WO1998049556A1 Antibody recognizing collagen fragments
11/05/1998WO1998049336A1 Metastasis models using green fluorescent protein (gfp) as a marker
11/05/1998WO1998049335A1 Construct and expression of a retrovirus chimerical envelope by vectors, and pharmaceutical compositions containing same
11/05/1998WO1998049329A1 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
11/05/1998WO1998049327A1 Recombinant fusion proteines based on bacterial adhesines for diagnostic assays
11/05/1998WO1998049326A1 Method for cleavage of fusion proteins
11/05/1998WO1998049325A1 Reporter fusion proteins, expression vectors and transfected cell lines thereof for the analysis of nuclear transport
11/05/1998WO1998049321A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
11/05/1998WO1998049318A1 Dna based anti-helicobacter vaccine composition
11/05/1998WO1998049317A2 Diagnosis and treatment of phosphatase- 0r kinase-related disorders
11/05/1998WO1998049314A2 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI)
11/05/1998WO1998049313A2 Characterization of granulocytic ehrlichia and methods of use
11/05/1998WO1998049312A2 Nucleic acids, proteins, and methods of use of granulocytic erhlichia
11/05/1998WO1998049311A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
11/05/1998WO1998049310A1 Mammalian cytokine-like factor 7
11/05/1998WO1998049309A1 Rat st38.2 chemokine
11/05/1998WO1998049308A1 Ngf variants
11/05/1998WO1998049307A1 Mammalian cytokine-like receptor
11/05/1998WO1998049306A1 Human c-type lectin
11/05/1998WO1998049305A1 Chimeric opg polypeptides
11/05/1998WO1998049304A1 Neuronal extracellular matrix protein
11/05/1998WO1998049303A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998WO1998049302A1 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998049301A1 New human retinoid binding protein
11/05/1998WO1998049300A2 Truncated vegf-related proteins
11/05/1998WO1998049299A1 Leukemia associated genes
11/05/1998WO1998049298A1 Heat shock-like protein
11/05/1998WO1998049297A1 Neuronal mort1 isoforms
11/05/1998WO1998049296A1 Human cerberus protein
11/05/1998WO1998049295A1 Ligand polypeptide for the g protein-coupled receptor from human pituitary glands
11/05/1998WO1998049294A1 Methods for detecting and reversing resistance to macrocyclic lactone compounds
11/05/1998WO1998049293A1 Human theta subunit of the gaba-a receptor
11/05/1998WO1998049292A2 Polypeptides associated with activator receptors and their biological applications
11/05/1998WO1998049291A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
11/05/1998WO1998049290A2 Syndecan interacting proteins and the use thereof
11/05/1998WO1998049289A1 HAMSTER EF-1α TRANSCRIPTIONAL REGULATORY DNA
11/05/1998WO1998049285A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
11/05/1998WO1998049278A1 INHIBITORS OF CELLULOLYTIC, XYLANOLYTIC AND β-GLUCANOLYTIC ENZYMES
11/05/1998WO1998049269A1 Genetically engineered animals containing null mutations in the neurofilament genes
11/05/1998WO1998049268A1 Natural killer cell lines and methods of use
11/05/1998WO1998049265A1 Regulators of ucp2 gene expression
11/05/1998WO1998049198A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/05/1998WO1998049197A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/05/1998WO1998049196A1 Calcitonin receptor-binding peptides
11/05/1998WO1998049195A1 Corona virus-like particles as tools for vaccination and therapy
11/05/1998WO1998049194A2 Ras-like protein
11/05/1998WO1998049192A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS)
11/05/1998WO1998049191A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
11/05/1998WO1998049188A1 Inhibitors of the jnk signal transduction pathway and methods of use
11/05/1998WO1998049185A1 Lepidopteran gaba-gated chloride channels
11/05/1998WO1998049184A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof
11/05/1998WO1998048841A1 Use of papovavirus capsid protein for delivery of genetic material
11/05/1998WO1998048837A1 Polyalkylene oxide-modified single chain polypeptides
11/05/1998WO1998048834A1 Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
11/05/1998WO1998048829A1 A vertebrate lens obtained from an ectodermal cell and methods of use thereof
11/05/1998WO1998048828A1 Method of treating sepsis
11/05/1998WO1998048827A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/05/1998WO1998048825A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
11/05/1998WO1998048824A1 Bioactive peptides derived from cocaine and amphetamine regulated transcript protein
11/05/1998WO1998048823A1 Anti-bacterial composition
11/05/1998WO1998048626A1 Methods and compositions for administering dna to mucosal surfaces
11/05/1998WO1998048614A1 Fruit-specific and ripening-regulation expansin genes to control fruit texture and softening
11/05/1998WO1998042737A3 Peptides for the treatment of systemic lupus erythematosus
11/05/1998WO1998039450A3 Surface protein (spsa protein) of streptococcus pneumoniae, deleted derivatives, expression system for said proteins and vaccine system with said proteins
1 ... 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 ... 2916